Facebook
Twitter
LinkedIn
ForwardSummit of the Americas on Immunotherapies for Hematologic Malignancies, Second Annual
Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in a thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.
This year’s meeting will be a half-day virtual symposium designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.
Agenda
| 9:00 - 9:10 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Acute Lymphoid Leukemia | |
| 9:10 - 9:30 a.m. | Updates on Treatment Approaches for Acute Lymphoblastic Leukemia Wendy Stock, M.D. |
| Acute Myeloid Leukemia | |
| 9:30 - 9:50 a.m. | Updates on Treatment Approaches for High-Risk AML Richard Stone, M.D. |
| 9:50 - 10:05 a.m. | Questions and Answers |
| 10:05 - 10:10 a.m. | Break |
| Multiple Myeloma | |
| 10:10 - 10:30 a.m. | Updates on Treatment Approaches for Multiple Myeloma Paul Richardson, M.D. |
| 10:30 - 10:50 a.m. | Updates on BCMA-Targeted Therapies for Multiple Myeloma Adam Cohen, M.D. |
| Allogeneic Stem Cell Transplants | |
| 10:50 - 11:10 a.m. | Updates on Indications for Allogeneic Stem Transplants in the Era of CARs Robert Soiffer, M.D. |
| 11:10 - 11:25 a.m. | Questions and Answers |
| 11:25 - 11:30 a.m. | Break |
| CAR Cell Therapies | |
| 11:30 - 11:50 a.m. | GPS-Guided CAR T-cell Therapies Robert Sackstein, M.D., Ph.D. |
| 11:50 a.m. - 12:10 p.m. | Do CARs Always Have to Be T Cells? Paul Lin, M.D. |
| 12:10 - 12:30 p.m. | Questions and Answers |
| 12:30 p.m. | Adjourn |
NOTE: Schedule subject to change.
Symposium Director
 | Guenther Koehne M.D., Ph.D. Deputy Director of Miami Cancer Institute Chief of Blood & Marrow Transplant and Hematologic Oncology Miami Cancer Institute Miami, Florida |
Faculty
 | Adam D. Cohen, M.D. Associate Professor of Medicine Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania |
 | Paul Lin M.D., Ph.D. Instructor at The University of Texas MD Anderson Cancer Center Houston, Texas |
 | Paul Richardson, M.D. Clinical Program Leader and Director Of Clinical Research Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute RJ Corman Professor of Medicine Harvard Medical School Boston, Massachusetts |
 | Robert Sackstein, M.D. Senior Vice President for Health Affairs Dean, Herbert Wertheim College of Medicine Florida International University Miami, Florida |
 | Robert Soiffer, M.D. Chief, Division of Hematologic Malignancies Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, Massachusetts |
 | Wendy Stock, M.D. Hematologist/ Oncologist Professor of Medicine University of Chicago Chicago, Illinois |
 | Richard M. Stone, M.D. Chief of Staff, Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, Massachusetts |
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 3.25 credit hours, CE Broker Course #20-840870, by the Florida Boards of Medicine, Osteopathic Medicine, and by the Florida Council of Physician Assistants.
This activity has also been approved for 3 credits for Nursing, 3.25 credits for Pharmacy, and 3.20 credits for Laboratory (hematology). Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 3.25 AMA PRA Category 1 Credit™
- 3.25 General certificate of attendance
- 3.20 Florida Board of Laboratory Personnel
- 3.00 Nurse Practitioners
- 3.00 Florida Board of Nursing
- 3.25 Florida Board of Pharmacy
The Summit of the Americas on Immunotherapies for Hematologic Malignancies will be a fully virtual symposium, allowing learners to access high-quality content and engage remotely from around the world in a platform that has been designed explicitly for this meeting.
| Compatibility Notice | |
 | Google Chrome is recommended to access the live stream to ensure the best experience and optimal connectivity. NOTE: Live streaming is not compatible with Internet Explorer (IE). |